Fri, Feb 27, 2015, 12:08 AM EST - U.S. Markets open in 9 hrs 22 mins


% | $
Quotes you view appear here for quick access.

International Stem Cell Corporation Message Board

  • Dooper55 Dooper55 Oct 21, 2010 10:48 AM Flag

    As reported Tuesday on "Cosmetic Business" website

    [Not new news, just new coverage]

    ISCO to launch enhanced delivery stem cell skin care 19-Oct-2010

    A joint venture between International Stem Cell Corporation (ISCO) and a new firm to be formed by marketing specialist and president of Millenium Wave Investments John Mauldin is to launch a line of stem cell-based skin care products developed by ISCO subsidiary Lifeline Skin Care Inc (LSC).

    The products – a day cream and a night-time version – are formulated using ISCO’s proprietary parthenogenetic stem cells, which do not require the use of fertilised embryos. Proteins from the stem cells are surrounded by a nanovesicle, allowing for extended shelf life and enhanced delivery of the product to the skin.

    The initial product offering is scheduled for November and will be to ISCO’s investors and followers. Next in line will be the 1.5 million readers of Mauldin’s economic letter, which the joint venture believes will allow LSC ample time to build an inventory of the stem cell extract before the products are sold on a broader scale.

    “This represents an amazing leap forward in the combination of a variety of cutting edge technologies to yield products that have the potential to find significant consumer acceptance,” commented ISCO chairman Kenneth Aldrich. “The anti-ageing market is extremely large and Lifeline Skin Care is offering something completely new and different. We are excited about the prospects.”


    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.060.00(+4.90%)Feb 26 3:57 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.